Bitte verwenden Sie diesen Link, wenn Sie dieses Dokument zitieren oder verlinken wollen: https://nbn-resolving.org/urn:nbn:de:gbv:9-opus-28228
Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 Trial
| Author: | Nikolai Siebert, Sascha Troschke-Meurer, Madlen Marx, Maxi Zumpe, Karoline Ehlert, Juliet Gray, Alberto Garaventa, Carla Manzitti, Shifra Ash, Thomas Klingebiel, James Beck, Victoria Castel, Dominique Valteau-Couanet, Hans Loibner, Ruth Ladenstein, Holger N. LodeORCiD |
|---|---|
| URN: | urn:nbn:de:gbv:9-opus-28228 |
| DOI: | https://doi.org/10.3390/cancers10100387 |
| ISSN: | 2072-6694 (eISSN) |
| Parent Title (English): | Cancers |
| Publisher: | MDPI |
| Document Type: | Article |
| Language: | English |
| Date of first Publication: | 2018/10/17 |
| Release Date: | 2020/03/10 |
| Tag: | HACA; anti-GD<sub>2</sub> immunotherapy; ch14.18/CHO; complement dependent cytotoxicity; long-term infusion; neuroblastoma; pain |
| GND Keyword: | - |
| Volume: | 10 |
| Issue: | 10 |
| Faculties: | Universitätsmedizin / Klinik und Poliklinik für Kinder- und Jugendmedizin |
| Licence (German): |  Creative Commons - Namensnennung |